Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Blueprint Medicines (BPMC)
NASDAQ:BPMC
Blueprint Medicines (BPMC) Ownership - Who Owns Blueprint Medicines?
523 Followers
Blueprint Medicines (BPMC) Ownership Overview
16.94% Insiders
45.54% Mutual Funds
18.07% Other Institutional Investors
19.45% Public Companies and
Individual Investors
The ownership structure of Blueprint Medicines (BPMC) stock is a mix of institutional, retail and individual investors. Approximately 63.61% of the company’s stock is owned by Institutional Investors, 16.94% is owned by Insiders and 19.45% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 07, 2024 | xxxxxxxxxxxxx | $420520 | |
| Jun 05, 2024 | xxxxxxxxxxxxx | $259263 | |
| Mar 26, 2024 | Jeffrey Albers Director | xxxxxxxxxxxxx | $1000583 |
| Mar 15, 2024 | Philina Lee Cco | xxxxxxxxxxxxx | $725277 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $283251 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $16905190 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $31790242 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $78465630 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,930,846 | Institution | 9.47% | 665,381,613 | |
| 5,268,858 | Institution | 8.41% | 591,113,179 | |
| 2,998,075 | Institution | 4.79% | 336,354,034 | |
| 2,149,647 | Institution | 3.43% | 241,168,897 | |
| 2,120,858 | Institution | 3.39% | 237,939,059 | |
| 2,076,664 | Institution | 3.32% | 232,980,934 | |
| 1,584,552 | Institution | 2.53% | 177,770,889 | |
| 1,068,644 | Institution | 1.71% | 119,891,170 | |
| 938,186 | Institution | 1.50% | 105,255,087 | |
| 839,400 | Institution | 1.34% | 94,172,286 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,268,858 | Institution | 8.41% | 591,113,179 | |
| 2,149,647 | Institution | 3.43% | 241,168,897 | |
| 2,120,858 | Institution | 3.39% | 237,939,059 | |
| 2,076,664 | Institution | 3.32% | 232,980,934 | |
| 1,584,552 | Institution | 2.53% | 177,770,889 | |
| 938,186 | Institution | 1.50% | 105,255,087 | |
| 839,400 | Institution | 1.34% | 94,172,286 | |
| 775,082 | Institution | 1.24% | 86,956,450 | |
| 748,626 | Institution | 1.20% | 83,988,351 | |
| 671,350 | Institution | 1.07% | 75,318,757 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,995,109 | Institution | 3.19% | 215,032,848 | |
| 1,709,646 | Institution | 2.73% | 191,805,185 | |
| 1,573,931 | Institution | 2.51% | 169,638,283 | |
| 985,936 | Institution | 1.57% | 112,091,064 | |
| 956,083 | Institution | 1.53% | 103,046,626 | |
| 884,626 | Institution | 1.41% | 95,344,990 | |
| 564,319 | Institution | 0.90% | 63,310,949 | |
| 453,184 | Institution | 0.72% | 50,842,713 | |
| 296,359 | Institution | 0.47% | 33,693,055 | |
| 234,072 | Institution | 0.37% | 25,228,280 |
FAQ
Who Owns Blueprint Medicines (BPMC)?
According to the latest TipRanks data, approximately 18.07% of the company's stock is held by institutional investors, 16.94% is held by insiders, and 19.45% is held by retail investors.
What percentage of Blueprint Medicines (BPMC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.07% of Blueprint Medicines (BPMC) stock is held by institutional investors.
What percentage of Blueprint Medicines (BPMC) stock is held by retail investors?
According to the latest TipRanks data, approximately 19.45% of Blueprint Medicines (BPMC) stock is held by retail investors.
Who owns the most shares of Blueprint Medicines (BPMC)?
Vanguard owns the most shares of Blueprint Medicines (BPMC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.